Concepedia

Scott D. Studenberg

SD

11

Publications

537

Citations

11

H-Index

1987

Active since

Affiliations

Research Triangle Park Foundation(Current)

University of North Carolina at Chapel Hill

GlaxoSmithKline (United Kingdom)

Scott D. Studenberg is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and health sciences.

Top concepts

Publications per year

1987–2004

11

Publications

11

Role of P-Glycoprotein on the CNS Disposition of Amprenavir (141W94), an HIV Protease Inhibitor

Joseph W. Polli, Jeanne L. Jarrett, Scott D. Studenberg et al. · Pharmaceutical Research · 1999 · 218 citations

Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir

Eric S. Furfine, Christopher Baker, Michael Hale et al. · Antimicrobial Agents and Chemotherapy · 2004 · 98 citations · Full text

Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers

Christine Falcoz, J.M. Jenkins, Carole Bye et al. · The Journal of Clinical Pharmacology · 2002 · 60 citations

Digoxin-like immunoreactivity eliminated from serum by centrifugal ultrafiltration before fluorescence polarization immunoassay of digoxin.

Robert H. Christenson, Scott D. Studenberg, S Beck-Davis et al. · Clinical Chemistry · 1987 · 39 citations · Full text

, , +23

Metabolic Disposition and Pharmacokinetics of [<sup>14</sup>C]‐Amprenavir, a Human Immunodeficiency Virus Type 1 (HIV‐1) Protease Inhibitor, Administered As a Single Oral Dose to Healthy Male Subjects

Brian M. Sadler, Gregory E. Chittick, Ronald E. Polk et al. · The Journal of Clinical Pharmacology · 2001 · 22 citations

Rows per page

1–5 of 11